10/13/2022 6:31:08 AM
BIOLASE Appoints Russell Morrow As Chief Dental Officer, Effective Nov 1
7/25/2022 6:34:16 AM
G1 Therapeutics Announces Addition Of Norman Sharpless To Board
7/7/2022 6:33:29 AM
BIOLASE Promotes Jennifer Bright To CFO And Steven Sandor To COO
7/5/2022 6:37:33 AM
BIOLASE Announces Partnership With TeamSmile
6/28/2022 8:31:38 AM
BIOLASE Announces Pricing Of $6.5 Mln Registered Direct Offering Priced At-the-Market
5/16/2022 6:35:34 AM
BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement
5/9/2022 6:52:15 AM
BIOLASE Names Kenneth Yale To Board
1/18/2022 8:38:57 AM
BIOLASE Collaborates With BMW Performance Center West And Winner Of BMW Sweepstakes
1/10/2022 6:36:20 AM
BIOLASE Sees Q4 Revenue To Be In Range Of $12.2 Mln To $12.5 Mln
1/6/2022 9:03:35 AM
BIOLASE Announces FDA 510(k) Clearance Of EdgePRO Laser-Assisted Microfluidic Irrigation Device For Endodontists
8/31/2021 9:13:40 AM
BIOLASE Announces Clinical Advisory Partnership With Endodontist Stephen Buchanan